In a sense, every investor is a growth investor. Even those who are primarily seeking income enjoy when the stocks they buy ...

FibroGen (NASDAQ:FGEN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the ...

AstraZeneca PLC (NASDAQ:AZN – Get Free Report) was the target of some unusual options trading activity on Thursday. Stock traders bought 153,234 call options on the stock. This represents an increase ...

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN) and reminds investors of the Feb.

Q4 2024 Earnings Call Transcript February 20, 2025 Ardelyx, Inc. reports earnings inline with expectations. Reported EPS is ...

AstraZeneca (LON:AZN – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at JPMorgan Chase ...

AstraZeneca PLC ADR closed 14.96% below its 52-week high of $87.68, which the company achieved on August 30th.

The company, now based in North Beach, has lost more than $2 billion over 29 years. Its only approved drug, called roxadustat ...

A California-based biotech turned heads on Thursday following an announcement that the company has agreed to sell its China ...

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best ...